Navigation Links
Central Texas Hospital Selects eCareSoft EHR Technology
Date:4/5/2011

AUSTIN, Texas, April 5, 2011 /PRNewswire/ -- eCareSoft announced today the completion of an agreement with Central Texas Hospital (CTH) to connect their network of six hospitals with eCareSoft's inpatient complete EHR and revenue cycle management technology.

CTH will incorporate eCareSoft's proprietary fast-track implementation program enabling their hospital network to expedite their 'meaningful use' activities in order to qualify for 2011-2012 stimulus funds.

"We are very pleased to be a part of Central Texas Hospital's electronic health records strategy," said Jorge Camargo, CEO of eCareSoft.  "Their interest in connecting their six hospitals with our technology is further validation that we are on the right path with our integrated solutions for small hospitals," added Camargo.

Many small and rural hospitals continue to face financial, technical and manpower challenges in transitioning to EHR solutions. eCareSoft offers a turnkey solution of technology, support and training for a fraction of the cost associated with traditional implementations. Using the company's fast-track implementation program, small hospitals can rollout the technology necessary to meet 'meaningful use' in as few as 120 days versus the traditional 8-12 months.

"Transitioning to electronic health records is an important step for us, not only to improve efficiencies across our hospital network, but to advance our goal of providing the highest level of patient care to our communities," stated Joe White, CFO Central Texas Hospital.  "eCareSoft offered us an expedited path to achieving 'meaningful use' and a flexible solution that really seemed to fit our small hospital environments," added White.

eCareSoft's EHR is an ONC-ATCB certified complete inpatient solution that utilizes a shared patient-centric database configuration rather than facilities centric, eliminating the redundant inputting of patient historical information each time an event
'/>"/>

SOURCE eCareSoft
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Gadavist for Central Nervous System Scans
2. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
3. Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development
4. Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia
5. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
6. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
7. Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study
8. Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study
9. Wound Management Technologies Adds Panama to Growing List of Distribution Points in Central America
10. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
11. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Germany und LONDON ... , Ziel der Zusammenarbeit sind ... genomischer Daten aus Plasmaproben zur Steuerung von Therapien ... werden kann  Neuer Bluttest basiert auf ... und soll auf Rotor-Gene Q, einer Automationsplattform der ...
(Date:7/28/2014)... 2014 OmPrompt today announces ... help it meet the global demand for customer ... logistics. Albion joins Shackleton Ventures.      ... the past 18 months OmPrompt has underpinned accelerated ... team and its operations. The new funding will ...
(Date:7/25/2014)... N.C. , July 25, 2014  In today,s ... is costly and challenging - as is managing a ... Is it possible - or even preferable ... If so, where can you combine resources and activities, ... These are just a few of ...
Breaking Medicine Technology:QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7OmPrompt Funded for Customer Automation Management Market Expansion 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2
... April 11, 2011 iCyt Mission Technology, Inc. (iCyt), ... announced the introduction of its new line of 405nm-excited ... Violet™ 421 products are part of the first commercial ... "This exciting new class of fluorescent probes will ...
... 11, 2011 Leading-edge Clinical Pharmacology and Cardiac ... announces the addition of Aziz Karim, BPharm, PhD, ... and advisor to Spaulding,s Clinical Pharmacology/Pharmacokinetic department.   ... the principles of Clinical Pharmacology and rational drug ...
Cached Medicine Technology:iCyt Unveils Exciting New Flow Cytometry Reagents Utilizing Innovative Fluorochrome Technology 2Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant 2
(Date:7/28/2014)... 2014 Qualis Health, one of ... organizations, has published a complimentary, online toolkit that ... patients and families in infection control. Tested ... the toolkit provides a step-by-step roadmap for implementing ... their families early in a hospital stay. , ...
(Date:7/28/2014)... North America Carotenoids & Antioxidants Market report defines and segments ... and forecast of revenue. This market is estimated to grow ... 2018, at a CAGR of 7.1% from 2013 to 2018. ... & Antioxidants Market report to get an idea of the ... segmentation in the market, and is supported by various tables ...
(Date:7/28/2014)... News) -- People with higher levels of brown fat ... new study suggests. Unlike white fat, which lowers ... insulin sensitivity, blood sugar control and fat-burning metabolism. ... Labros Sidossis, a professor of internal medicine in the ... Medical Branch at Galveston, said in a university ...
(Date:7/28/2014)... decision tree analysis, incorporating Donabedian,s model, is a ... available quality standards, guidelines, recommendations and indicators ... standards for radiation therapy, according to a study ... Practical Radiation Oncology (PRO), the official clinical ... Oncology (ASTRO). , Guidelines, recommendations and indicators may ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 A young ... to the all-too-often stories in the media today about ... occur in a matter of minutes in a hot ... to the Office of Emergency Medical Services at NHTSA. ... app for smartphones. Realizing that it’s all too easy ...
Breaking Medicine News(10 mins):Health News:Patient Engagement in Hospital Infection Control: Online Toolkit Provides a New Solution 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Healthy 'Brown Fat' May Cut Odds for Obesity, Diabetes 2Health News:Two-step decision tree analysis helps inform updates of RT best practices, quality standards 2Health News:Two-step decision tree analysis helps inform updates of RT best practices, quality standards 3Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2
... find themselves in a sticky situation having failed to meet ... lapses in// sticking to rules pertaining to blood safety, ... the total penalty toll against the American Red Cross ... the organization had been fined close to $5.7 million, ...
... amyotrophic lateral sclerosis (ALS), the most common form of ... successful compiling of genetic information on more than 1,000 ... by The Packard Center for ALS Research at Johns ... (NINDS) and the ALS Association, present their initial findings ...
... a lot of other countries, Japan is keen to ... universities, which are currently restricted only to those// who ... of the undergraduate courses like biotechnology and neurosciences to ... prime minister. He is also a professor at the ...
... to the needs of about 1,000 people annually. ... Award for Excellence in Weight// Management 2006 to ... standards that were maintained by this clinic. Glowing ... that offer simple,yet comprehensive solutions to treat obesity. ...
... South Africans are coming forward to seek counseling and ... HIV figures, the Department of Health has reported.// ... have utilized the screening services since 2000, thanks to ... their status. In 2005/06, nearly 1.7-million people underwent the ...
... Welfare stressed the urgency to focus on health and education. ... million people are suffering with HIV/AIDS, and also putting a ... be noted that more than 50 percent of the AIDS ... to be women. Ramadoss expressed how the campaign had slightly ...
Cached Medicine News:Health News:American Red Cross Face Fines After Blood Safety Lapses 2Health News:First International Gene Screen for Typical ALS Is on Track 2
Double Ended Occluders...
49 pinholes, black...
Double Ended Occluders...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Medicine Products: